Open AccessDaily Oral Grepafloxacin vs. Twice Daily OralDoxycycline in the Treatment of Chlamydia trachomatisEndocervical Infection
Author(s) -
William M. McCormack,
David H. Martin,
Edward W. Hook,
R B Jones
Publication year - 1998
Publication title -
infectious diseases in obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.656
H-Index - 48
eISSN - 1098-0997
pISSN - 1064-7449
DOI - 10.1155/s1064744998000210
Subject(s) - medicine , chlamydia trachomatis , cervicitis , doxycycline , chlamydia , randomized controlled trial , gynecology , gastroenterology , antibiotics , immunology , microbiology and biotechnology , biology
Objective: To compare the efficacy and safety of a 7-day course of treatment with oral grepafloxacin,400 mg once daily, and oral doxycycline, 100 mg twice daily, in patients with chlamydial cervicitis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom